PLASMA TRIGLYCERIDES DETERMINE LOW-DENSITY-LIPOPROTEIN COMPOSITION, PHYSICAL-PROPERTIES, AND CELL-SPECIFIC BINDING IN CULTURED-CELLS

被引:79
作者
MCKEONE, BJ [1 ]
PATSCH, JR [1 ]
POWNALL, HJ [1 ]
机构
[1] UNIV INNSBRUCK, DEPT MED, A-6020 INNSBRUCK, AUSTRIA
关键词
ATHEROSCLEROSIS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; APOLIPOPROTEIN-B; APO-B/E RECEPTOR;
D O I
10.1172/JCI116411
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The relationship between the plasma triglycerides and the LDL triglycerides of 30 normal and 48 hypertriglyceridemic subjects has been quantified; the data fit a simple adsorption isotherm, LDL triglyceride / (LDL triglyceride + LDL cholesterol ester) = 0.65 plasma triglyceride/(464 + plasma triglyceride). In vitro transfer of triglyceride from concentrated VLDL to VLDL-depleted plasma produced triglyceride-rich LDL that had similar properties. LDL uptake by HepG2 cells increased with LDL triglyceride content whereas the reverse was found with skin fibroblasts. At 37-degrees-C, the cores of both normal and hypertriglyceridemic LDL were isotropic liquids. Circular dichroic spectra revealed no difference in the secondary structure of normal and triglyceride-rich LDL. The affinity of monoclonal antibody MB47, which binds to the receptor ligand of apo B-100 was independent of LDL triglyceride content. MB3, which binds near residue 1022 of apo B-100, showed a triglyceride-dependent decrease in affinity for LDL from hypertriglyceridemic subjects and from in vitro incubations. LDL with an elevated triglyceride content formed in vitro had reduced proteolytic cleavage of apo B-100 by Staphylococcus aureus V8 protease. From these data, we infer that (a) LDL triglyceride is a predictable function of plasma triglyceride, (b) triglyceride induces subtle changes in apo B-100 structure at a site that is remote from the putative receptor binding ligand, and (c) the triglyceride-dependent receptor-binding determinants of apo B-100 are recognized differently by fibroblasts and HepG2 cells.
引用
收藏
页码:1926 / 1933
页数:8
相关论文
共 61 条
[1]  
ADELMAN SJ, 1984, J BIOL CHEM, V259, P3844
[2]   ISOLATION AND CHARACTERIZATION OF HUMAN-PLASMA LIPID TRANSFER PROTEINS [J].
ALBERS, JJ ;
TOLLEFSON, JH ;
CHEN, CH ;
STEINMETZ, A .
ARTERIOSCLEROSIS, 1984, 4 (01) :49-58
[3]   PLASMA TRIGLYCERIDE AND CORONARY HEART-DISEASE [J].
AUSTIN, MA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :2-14
[4]  
AVIRAM M, 1988, J BIOL CHEM, V263, P16842
[5]  
BARTER PJ, 1982, LIPOPROTEIN KINETICS, P245
[6]   DEGRADATION OF CATIONIZED LOW-DENSITY LIPOPROTEIN AND REGULATION OF CHOLESTEROL-METABOLISM IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA FIBROBLASTS [J].
BASU, SK ;
GOLDSTEIN, JL ;
ANDERSON, RGW ;
BROWN, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3178-3182
[7]   LIVER-TRANSPLANTATION TO PROVIDE LOW-DENSITY-LIPOPROTEIN RECEPTORS AND LOWER PLASMA-CHOLESTEROL IN A CHILD WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].
BILHEIMER, DW ;
GOLDSTEIN, JL ;
GRUNDY, SM ;
STARZL, TE ;
BROWN, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (26) :1658-1664
[8]   CURRENT THERAPY FOR HYPERCHOLESTEROLEMIA [J].
BLUM, CB ;
LEVY, RI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (24) :3582-3587
[9]  
Brown M S, 1979, Recent Prog Horm Res, V35, P215
[10]  
CHAPPELL DA, 1991, J BIOL CHEM, V266, P19296